Literature DB >> 961449

Prostaglandins, a link between renal hydro- and hemodynamic in dogs.

U B Olsen, M P Magnussen, E Eilertsen.   

Abstract

An increase of the intrarenal pressure to 40 mmHg induced by ureteral constriction or by kidney compression is shown to be followed by increased renal blood flow in anesthetized dogs. This hyperemia is probably the result of enhanced intrarenal prostaglandin activity since it is followed by increased urinary prostaglandin E excretion and is abolished by indomethacin pretreatment. The increase of renal blood flow seems to be due to dilation of the afferent arteriole in order to maintain the filtration pressure. The glomerular filtration rate is thus severely depressed in indomethacin pretreated dogs. Urine and electrolyte excretion is comparably redcued during elevated intrarenal pressure in non-pretreated and in indomethacin pretreated dogs, which suggests that factors other than glomerular filtration rate are involved. Urine osmolarity is positively correlated with renal blood flow, and urine osmolarity increases during elevated intrarenal pressure in non pretreated dogs, whilst urine osmolarity remains unchanged in dogs pretreated with indomethacin.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 961449     DOI: 10.1111/j.1748-1716.1976.tb10276.x

Source DB:  PubMed          Journal:  Acta Physiol Scand        ISSN: 0001-6772


  4 in total

1.  Dehydration-induced increase in aquaporin-2 protein abundance is blocked by nonsteroidal anti-inflammatory drugs.

Authors:  Erin Baggaley; Søren Nielsen; David Marples
Journal:  Am J Physiol Renal Physiol       Date:  2010-02-03

2.  Ondansetron versus diclofenac sodium in the treatment of acute ureteral colic: a double blind controlled trial.

Authors:  U Ergene; M Pekdemir; E Canda; Z Kirkali; J Fowler; F Coşkun
Journal:  Int Urol Nephrol       Date:  2001       Impact factor: 2.370

3.  Clinical pharmacokinetics of ketoprofen after single intravenous administration as a bolus or infusion.

Authors:  D Debruyne; B Hurault de Ligny; J P Ryckelynck; F Albessard; M Moulin
Journal:  Clin Pharmacokinet       Date:  1987-03       Impact factor: 6.447

Review 4.  Bumetanide. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic use.

Authors:  A Ward; R C Heel
Journal:  Drugs       Date:  1984-11       Impact factor: 9.546

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.